Bank of America Corporation »

Candel Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $25 18 1.44
2022-12-31 $40 22 1.82
2022-06-30 $0 150 0.00
2021-12-31 $8.0k 1.1k 7.35